EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cytomegalovirus latency—the sum of subtleties

Meaghan H Hancock iD, Patrizia Caposio, Donna Collins-McMillen, Nicole L Diggins iD, Byeong-Jae Lee, Samuel Medica, Daniel N Streblow iD, Timothy White, Andrew D Yurochko iD, Felicia Goodrum iD

Journal of Virology · 2025

DOI: 10.1128/jvi.00664-25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Virology, 2025. Verfasst von Meaghan H Hancock und 9 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Gene Therapy Institute, Oregon Health and Science Institute, Beaverton, Oregon, USA. Hauptthemen laut MEDLINE: Virus Latency, Cytomegalovirus, Cytomegalovirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human cytomegalovirus (HCMV) is a betaherpesvirus, which, like all herpesviruses, establishes a life-long latent infection while retaining the ability to reactivate its replicative program. While HCMV likely reactivates frequently and sporadically in healthy individuals and typically without disease, reactivation poses a serious disease threat in the immunocompromised. The latent program of HCMV is complex and has been challenging to define due to limitations in appropriate experimental model systems related to virus-host species specificity, limited identification of in vivo latent reservoirs, and the dynamic cellular differentiation of the hematopoietic latency reservoir that is directly linked to latency maintenance and reactivation phenotypes. Here, we review the current understanding of HCMV latency, with a focus on cross-cutting principles derived collectively from in vitro experimental culture models and in vivo animal models using the corresponding orthologs (CMVs) to HCMV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus LatencyCytomegalovirusCytomegalovirus InfectionsHumansAnimalsVirus ActivationDisease Models, Animal

Stichwörter der Autor:innen

cytomegalovirusherpesviruslatencyvirus-host interactions

Autor:innen und Institutionen

  • Vaccine and Gene Therapy Institute, Oregon Health and Science Institute, Beaverton, Oregon, USA.
  • Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
  • Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.

ORCID-Profile: Meaghan H Hancock, Nicole L Diggins, Daniel N Streblow, Andrew D Yurochko, Felicia Goodrum

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Hancock, M. H., Caposio, P., Collins-McMillen, D., Diggins, N. L., Lee, B. J., Medica, S., Streblow, D. N., White, T., Yurochko, A. D., & Goodrum, F. (2025). Cytomegalovirus latency—the sum of subtleties. Journal of Virology. https://doi.org/10.1128/jvi.00664-25

Vancouver

Hancock MH, Caposio P, Collins-McMillen D, Diggins NL, Lee BJ, Medica S, et al. Cytomegalovirus latency—the sum of subtleties. Journal of Virology. 2025. doi:10.1128/jvi.00664-25

BibTeX
@article{Hancock2025,
  author = {Hancock, Meaghan H and Caposio, Patrizia and Collins-McMillen, Donna and Diggins, Nicole L and Lee, Byeong-Jae and Medica, Samuel and Streblow, Daniel N and White, Timothy and Yurochko, Andrew D and Goodrum, Felicia},
  title = {Cytomegalovirus latency—the sum of subtleties},
  journal = {Journal of Virology},
  year = {2025},
  doi = {10.1128/jvi.00664-25}
}
Kostenlos starten →